High Density Lipoprotein Stimulated Migration of Macrophages Depends on the Scavenger Receptor Class B, Type I, PDZK1 and Akt1 and Is Blocked by Sphingosine 1 Phosphate Receptor Antagonists

被引:48
作者
Al-Jarallah, Aishah
Chen, Xing
Gonzalez, Leticia
Trigatti, Bernardo L. [1 ]
机构
[1] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada
关键词
PROTEIN-KINASE-C; ENDOTHELIAL NITRIC-OXIDE; MONOCYTE-DERIVED CELLS; E-DEFICIENT MICE; SR-BI; ATHEROSCLEROSIS REGRESSION; CHOLESTEROL TRANSPORT; INTERACTING DOMAIN; RECONSTITUTED HDL; PERTUSSIS TOXIN;
D O I
10.1371/journal.pone.0106487
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HDL carries biologically active lipids such as sphingosine-1-phosphate (S1P) and stimulates a variety of cell signaling pathways in diverse cell types, which may contribute to its ability to protect against atherosclerosis. HDL and sphingosine-1-phosphate receptor agonists, FTY720 and SEW2871 triggered macrophage migration. HDL-, but not FTY720-stimulated migration was inhibited by an antibody against the HDL receptor, SR-BI, and an inhibitor of SR-BI mediated lipid transfer. HDL and FTY720-stimulated migration was also inhibited in macrophages lacking either SR-BI or PDZK1, an adaptor protein that binds to SR-BI's C-terminal cytoplasmic tail. Migration in response to HDL and S1P receptor agonists was inhibited by treatment of macrophages with sphingosine-1-phosphate receptor type 1 (S1PR1) antagonists and by pertussis toxin. S1PR1 activates signaling pathways including PI3K-Akt, PKC, p38 MAPK, ERK1/2 and Rho kinases. Using selective inhibitors or macrophages from gene targeted mice, we demonstrated the involvement of each of these pathways in HDL-dependent macrophage migration. These data suggest that HDL stimulates the migration of macrophages in a manner that requires the activities of the HDL receptor SR-BI as well as S1PR1 activity.
引用
收藏
页数:14
相关论文
共 131 条
[1]   Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis [J].
Ackah, E ;
Yu, J ;
Zoellner, S ;
Iwakiri, Y ;
Skurk, C ;
Shibata, R ;
Ouchi, N ;
Easton, RM ;
Galasso, G ;
Birnbaum, MJ ;
Walsh, K ;
Sessa, WC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2119-2127
[2]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[3]   A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways [J].
Al-Jarallah, Aishah ;
Trigatti, Bernardo L. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (12) :1239-1248
[4]   Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols [J].
Andreadi, CK ;
Howells, LM ;
Atherfold, PA ;
Manson, MM .
MOLECULAR PHARMACOLOGY, 2006, 69 (03) :1033-1040
[5]   The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs [J].
Androulidaki, Ariadne ;
Iliopoulos, Dimitrios ;
Arranz, Alicia ;
Doxaki, Christina ;
Schworer, Steffen ;
Zacharioudaki, Vassiliki ;
Margioris, Andrew N. ;
Tsichlis, Philip N. ;
Tsatsanis, Christos .
IMMUNITY, 2009, 31 (02) :220-231
[6]  
Arboleda MJ, 2003, CANCER RES, V63, P196
[7]   High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function [J].
Argraves, Kelley M. ;
Gazzolo, Patrick J. ;
Groh, Eric M. ;
Wilkerson, Brent A. ;
Matsuura, Bryan S. ;
Twal, Waleed O. ;
Hammad, Samar M. ;
Argraves, W. Scott .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) :25074-25081
[8]  
Argraves KM, 2007, J LIPID RES
[9]   Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling [J].
Assanasen, C ;
Mineo, C ;
Seetharam, D ;
Yuhanna, IS ;
Marcel, YL ;
Connelly, MA ;
Williams, DL ;
de la Llera-Moya, M ;
Shaul, PW ;
Silver, DL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :969-977
[10]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20